What does CUSIP G6461G106 represent in this 13F holders report?

CUSIP G6461G106 is the security identifier for NFH - NEW FRONTIER HEALTH CORP - ORD SHS used to aggregate holder disclosures.

How many institutions held NFH - NEW FRONTIER HEALTH CORP - ORD SHS in Q2 2020?

25 institutional investors reported NFH - NEW FRONTIER HEALTH CORP - ORD SHS for Q2 2020. Use the holders table for investor-level position and value details.

NEW FRONTIER HEALTH CORP - ORD SHS (NFH)

CUSIP: G6461G106

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / ORD SHS
Total 13F shares: 59,331,440
Share change: +1,237,704
Total reported value: $491,263,000
Price per share: $8.28
Number of holders: 25
Value change: +$10,255,858
Number of buys: 12
Number of sells: 7

Quarterly Holders Quick Answers

What is CUSIP G6461G106?
CUSIP G6461G106 identifies NFH - NEW FRONTIER HEALTH CORP - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP G6461G106:

Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020

Institutional Holders of NEW FRONTIER HEALTH CORP - ORD SHS (NFH) as of Q2 2020

As of 30 Jun 2020, NEW FRONTIER HEALTH CORP - ORD SHS (NFH) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 59,331,440 shares. The largest 10 holders included Vivo Capital, LLC, Capital Research Global Investors, Fosun International Ltd, Aspex Management (HK) Ltd, MORGAN STANLEY, York Capital Management Global Advisors, LLC, BAMCO INC /NY/, Capital International Investors, UBS OCONNOR LLC, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 25 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.